| Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and … N Nasiri-Ansari, C Nikolopoulou, K Papoutsi, I Kyrou, CS Mantzoros, ... International journal of molecular sciences 22 (2), 818, 2021 | 230 | 2021 |
| Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant–antioxidant status A Gizi, I Papassotiriou, F Apostolakou, C Lazaropoulou, M Papastamataki, ... Blood Cells, Molecules, and Diseases 46 (3), 220-225, 2011 | 141 | 2011 |
| Hydroxyurea Therapy in Thalassemiaa D Loukopoulos, E Voskaridou, A Stamoulakatou, Y Papassotiriou, ... Annals of the New York Academy of Sciences 850 (1), 120-128, 1998 | 96 | 1998 |
| Clinical and laboratory effects of long‐term administration of hydroxyurea to patients with sickle‐cell/β‐thalassaemia E Voskaridou, V Kalotychou, D Loukopoulos British journal of haematology 89 (3), 479-484, 1995 | 83 | 1995 |
| Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1) Y Rombos, R Tzanetea, K Konstantopoulos, S Simitzis, C Zervas, ... Haematologica 85 (2), 115-117, 2000 | 62 | 2000 |
| Reduction of the clinical severity of sickle cell/β-thalassemia with hydroxyurea: The experience of a single center in Greece D Loukopoulos, E Voskaridou, V Kalotychou, M Schina, A Loutradi, ... Blood Cells, Molecules, and Diseases 26 (5), 453-466, 2000 | 57 | 2000 |
| Adhesion molecules and high‐sensitivity C‐reactive protein levels in patients with sickle cell beta‐thalassaemia I Kanavaki, P Makrythanasis, C Lazaropoulou, A Kattamis, R Tzanetea, ... European journal of clinical investigation 42 (1), 27-33, 2012 | 30 | 2012 |
| The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta (s)/beta (thal) anemia patients M Politou, V Kalotychou, M Pissia, Y Rombos, N Sakellaropoulos, ... Haematologica 89 (4), 490-492, 2004 | 30 | 2004 |
| Iron metabolism gene expression in human skeletal muscle A Polonifi, M Politou, V Kalotychou, K Xiromeritis, M Tsironi, V Berdoukas, ... Blood Cells, Molecules, and Diseases 45 (3), 233-237, 2010 | 25 | 2010 |
| Hereditary hyperferritinemia cataract syndrome in three unrelated families of western Greek origin caused by the C39> G mutation of L-ferritin IRE G Papanikolaou, H Chandrinou, E Bouzas, D Contopoulos-Ioannidis, ... Blood Cells, Molecules, and Diseases 36 (1), 33-40, 2006 | 25 | 2006 |
| Amelioration of painful crises in sickle cell disease by venesections Y Rombos, R Tzanetea, V Kalotychou, K Konstantopoulos, S Simitzis, ... Blood Cells, Molecules, and Diseases 28 (2), 283-287, 2002 | 25 | 2002 |
| Analysis of the A (TA) nTAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease V Kalotychou, K Antonatou, R Tzanetea, E Terpos, D Loukopoulos, ... Blood Cells, Molecules, and Diseases 31 (1), 38-42, 2003 | 24 | 2003 |
| Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease I Armenis, V Kalotychou, R Tzanetea, I Moyssakis, D Anastasopoulou, ... Annals of hematology 98, 1561-1572, 2019 | 19 | 2019 |
| Correlation of Fc-γ RIIA polymorphisms with latent Epstein–Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas PT Diamantopoulos, V Kalotychou, K Polonyfi, M Sofotasiou, ... Leukemia & Lymphoma 54 (9), 2030-2034, 2013 | 19 | 2013 |
| Plesiomonas shigelloides sepsis in a thalassemia intermedia patient V Kalotychou, Y Rombos, R Tzanetea, K Konstantopoulos, C Spiliopoulou, ... Scandinavian journal of infectious diseases 34 (9), 687-689, 2002 | 18 | 2002 |
| Prognostic value of T786C and G894T eNOS polymorphisms in sickle cell disease I Armenis, V Kalotychou, R Tzanetea, P Kollia, Z Kontogeorgiou, ... Nitric Oxide 62, 17-23, 2017 | 17 | 2017 |
| Vitamin D interferes with glucocorticoid responsiveness in human peripheral blood mononuclear target cells E Kassi, N Nasiri-Ansari, E Spilioti, V Kalotychou, PE Apostolou, ... Cellular and molecular life sciences 73, 4341-4354, 2016 | 15 | 2016 |
| UGT1A1* 28 polymorphism in chronic lymphocytic leukemia: the first investigation of the polymorphism in disease susceptibility and its specific cytogenetic abnormalities M Karakosta, V Kalotychou, A Kostakis, G Pantelias, I Rombos, ... Acta Haematologica 132 (1), 59-67, 2014 | 11 | 2014 |
| Contribution of G71R mutation to Gilbert’s syndrome phenotype in a Greek patient: A case report V Kalotychou, M Karakosta, R Tzanetea, A Stamoulakatou, ... World Journal of Gastrointestinal Pharmacology and Therapeutics 2 (5), 42, 2011 | 9 | 2011 |
| Polymorphisms of uridine glucuronosyltransferase gene and irinotecan toxicity: low dose does not protect from toxicity M Tziotou, V Kalotychou, A Ntokou, R Tzanetea, I Armenis, M Varsou, ... ecancermedicalscience 8, 2014 | 8 | 2014 |
